Compared to GFV LLC, which have already taken a valid patent for the tesetaxel synthesis, Genta is behind. But this isn't an issue, because it's the priority date, which counts always first, when a patent was applied for.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.